This functionality is implemented using Javascript. It cannot work without it, etc...

Latent TB Infection Guideline

2018 Revision

Table of Contents

The live links below will take you to the CDPH website where they can be downloaded individually. Please note that these pieces have the same content as the information provided in this guideline.

Introduction (page 2)

Background (page 2)

Who to Test: (page 3)

California Tuberculosis Adult Risk Assessment and User Guide (September 2018) (page 4)
California Tuberculosis Pediatric Risk Assessment and User Guide (September 2018) (page 7)

Selecting a Test for Latent TB Infection (LTBI) (page 11)

Evaluating Patients with a Positive TB Test (page 12)

Choice of Treatment for Latent TB Infection (LTBI) (page 15)

12 dose Isoniazid (INH) + Rifapentine Regimen for Latent TB Infection Treatment (September 2018) (page 17)
Rifampin for Latent TB Infection Treatment (September 2018) (page 19)
Isoniazid (INH) for Latent TB Infection Treatment (September 2018) (page 21)

Resources (page 23)

References (page 24)